Back to 
Arrowstreet Capital, Limited Partnership
Arrowstreet Capital, Limited PartnershipGSGSK1
Showing 0 of 16 quarters
Position history for Arrowstreet Capital, Limited Partnership's holdings in GLAXOSMITHKLINE PLC-SPON ADR
As of its Q2 2022 13F, Arrowstreet Capital held 9,989,614 shares of GSK1 (Glaxosmithkline), worth $434.8M. Arrowstreet Capital's 13F filings listed GSK1 from Q4 2018 to Q2 2022, 15 quarterly filings. GSK1 was 0.6% of Arrowstreet Capital's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.